• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mersana Therapeutics Inc (NQ: MRSN )

    2.550 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1
    Open 2.550
    Bid (Size) 2.500 (1)
    Ask (Size) 2.760 (13)
    Prev. Close 2.550
    Today's Range 2.550 - 2.550
    52wk Range 1.150 - 6.280
    Shares Outstanding 71,761,525
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    MRSN Stock Earnings: Mersana Therapeutics Misses EPS, Misses Revenue for Q2 2024
    MRSN stock results show that Mersana Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +12.33%
    +12.33%
    1 Month
    +28.14%
    +28.14%
    3 Month
    +74.66%
    +74.66%
    6 Month
    +3.45%
    +3.45%
    1 Year
    +96.15%
    +96.15%

    More News

    Read More
    MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
    Via Benzinga
    A Preview Of Mersana Therapeutics's Earnings
    Via Benzinga
    What To Know About Citigroup's Upgrade of Mersana Therapeutics
    Via Benzinga
    Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    A Preview Of Mersana Therapeutics's Earnings
    Via Benzinga
    Why Mersana Therapeutics Stock Is Plunging Today?
    Via Benzinga
    Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
    Via InvestorPlace
    Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
    Via PressReach
    How To Invest In The Healthcare Sector
    Via Talk Markets
    Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Dow Dips Over 200 Points; McDonald's Tops Q2 Expectations
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    Via Benzinga
    Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.